用于骨质疏松症治疗的细胞膜模仿,骨定位和ROS控制释放剂功能化的合成纳米粒子
Weijun Zhang1, Ye Zhang1, Zhengan Hao1
1Department of Orthopedic Surgery, The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou City, Zhejiang Province, PR China; Orthopedics Research Institute of Zhejiang University, Hangzhou City, Zhejiang Province, PR China; Key Laboratory of Motor System Disease Research and Precision Therapy of Zhejiang Province, Hangzhou City, Zhejiang Province, PR China; Clinical Research Center of Motor System Disease of Zhejiang Province, PR China.
概括
一个新的纳米粒子 (ALN@BMSCM@PLGA-TK-PEG-SS31) 有效地准骨,减少氧化应激,并在骨质疏松症模型中促进骨质量. 这种纳米粒子在治疗绝经后的骨质疏松症方面表现有前途,副作用最小.
科学领域:
- 生物材料科学 生物材料科学
- 纳米技术纳米技术
- 骨质疏松症研究研究
背景情况:
- 绝经后的骨质疏松症是一种常见的退行性骨病,治疗选择有限.
- 目前治疗骨质疏松症的方法往往缺乏特异性,并表现出多样化的目标.
- 需要创新的治疗策略来应对骨质疏松症管理中的挑战.
研究的目的:
- 为了合成和描述一种新的纳米粒子,ALN@BMSCM@PLGA-TK-PEG-SS31,用于骨质疏松症治疗.
- 评估纳米粒子向骨组织和减轻氧化应激的能力.
- 评估纳米粒子在骨质疏松症的体外和体内模型中的治疗疗效.
主要方法:
- 一个核心纳米粒子 (PLGA-TK-PEG-SS31) 的合成,该纳米粒子被骨髓介质干细胞膜 (BMSCMs) 覆盖,并包含DSPE-PEG-ALN.
- 评估纳米粒子大小,ROS触发的药物释放和免疫逃避能力.
- 在体外研究评估抑制骨质细胞形成和促进骨质分化.
- 使用卵巢切除诱导的骨质疏松症小鼠模型进行体内研究,以评估治疗效果.
主要成果:
- 合成的纳米粒子 (ALN@BMSCM@PLGA-TK-PEG-SS31) 证明了有效的骨定位和逃避免疫细胞化.
- 该纳米粒子成功降低了骨组织中反应性氧物种 (ROS) 的产生.
- 在体外,纳米颗粒抑制了骨质细胞生成,并促进了骨质分化.
- 在体内,纳米粒子显著增加了骨质量,并改善了骨质疏松症小鼠模型中的氧化应激,没有明显的副作用.
结论:
- ALN@BMSCM@PLGA-TK-PEG-SS31表现出双重治疗效果,同时解决骨再吸收和骨形成的问题.
- 纳米颗粒的设计促进了有针对性的输送,ROS清理和增强骨再生.
- 这种新型纳米粒子代表了治疗绝经后骨质疏松症的有希望的候选治疗方法.
相关概念视频
Essential Minerals for Bone Health
3.8K
The minerals contained in all of the food we consume are essential for our organ systems. However, certain essential minerals, such as calcium, phosphorus, magnesium, manganese, and fluoride, largely affect bone health.
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
Calcium and Phosphorus
Calcium is a critical component of bones, especially in the form of calcium phosphate and calcium carbonate. Since the body cannot make calcium, it must be obtained from the diet. However, calcium cannot be absorbed from the small intestine without...
3.8K
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K


